Live feed
·
PRReleasevia Quantisnow
Burning Rock Biotech Limited logo

Burning Rock's OncoGuide™ OncoScreen™ Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer

ByQuantisnow·Wall Street's wire, on your screen.
BNR· Burning Rock Biotech Limited
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BNR (Burning Rock Biotech Limited) and more on Quantisnow.